Robot-assisted rehabilitation for upper limb recovery
Feasibility and Cost of Robot-assisted Upper Limb Rehabilitation with Different Levels of Supervision: an Interventional Study
This study is testing whether a robot-assisted therapy device can help people with upper limb movement problems recover better and if it can be used easily in rehab clinics.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Swiss Federal Institute of Technology Academic / other |
| Locations | 2 sites (Brissago and 1 other locations) |
| Trial ID | NCT06725784 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility and cost-effectiveness of using the ReHandyBot, a robot-assisted rehabilitation device, for patients with upper limb sensorimotor deficits. The device allows patients to engage in therapy with minimal to no supervision, potentially increasing the therapy dose while reducing the need for additional resources. The study aims to assess how well the ReHandyBot can be integrated into rehabilitation clinics and perform a cost-benefit analysis comparing different levels of supervision during therapy. Additionally, it will investigate the intensity of use and the effectiveness of the therapy in improving patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 to 90 with upper limb deficits resulting from various medical conditions that could benefit from robotic therapy.
Not a fit: Patients with pathologies that interfere with training using the ReHandyBot may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance rehabilitation outcomes for patients with upper limb impairments, leading to improved independence in daily activities.
How similar studies have performed: Other studies have shown promise in using robotic-assisted therapy for rehabilitation, indicating that this approach could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed Consent signed by the subject. * Female and male patients between 18 and 90 years old * Presence of an upper limb deficit derived from any disease or event that, according to the responsible clinicians, could be improved by therapy with ReHandyBot. Exclusion Criteria: * Pathologies that may interfere with the training with ReHandyBot.
Where this trial is running
Brissago and 1 other locations
- Clinica Hildebrand Centro di riabilitazione Brissago — Brissago, Switzerland (Recruiting)
- Clinica Hildebrand Centro Ambulatoriale Lugano — Lugano, Switzerland (Recruiting)
Study contacts
- Study coordinator: Giada Devittori, Dr.
- Email: giada.devittori@hest.ethz.ch
- Phone: 0041445107234
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.